Digital Solutions in Heart Therapy (DIGNITY) - a Randomized Controlled Trial Using Telemedicine for Heart Failure Treatment
This study aims to assess the safety and effectiveness of telemedicine guided strategy on guideline-directed medical therapy (GDMT) optimization in hospitalized patients with heart failure in comparison to usual care in Switzerland.
• Age \> 18 years at the time of hospital admission
• Ability to use a (smart)phone and/or tablet for the follow-up
• Documented left ventricular ejection fraction (LVEF) \> 40% assessed within preceding 12 months
• Not treated with optimal doses of oral HF therapies within 2 days before anticipated hospital discharge for acute HF in at least one of the medication categories (for details see Table 1 on page 10)
• Hospitalized due to acute HF decompensation.
• Specific measures within 24 hours prior to randomization
‣ Systolic blood pressure \> 100 mmHg, and heart rate \> 60bpm
⁃ Serum potassium \< 5mmol/L